Vimarsana
Biggest News Aggregation in the World

Page 2 - Comics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Comics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Comics Inc Today - Breaking & Trending Today

Were This Week's Marvel Comics Printed On Toilet Paper? - Vimarsana News

Were This Week's Marvel Comics Printed On Toilet Paper?

As I mentioned in my Saga preview yesterday, the fact that Image Comics has a $2.99 comic printed on decent quality paper and cover, while Marvel have

The Promise Collection 1947: True Crime, True Love, Synthetic Gems - Vimarsana News

The Promise Collection 1947: True Crime, True Love, Synthetic Gems

The Promise Collection is a group of high grade comics from 1939-1952, and late 1947 was about true crime, true love, and synthetic gems.

Mutant Gene-Targeted Immunotherapy Approach Developed - Vimarsana News

Mutant Gene-Targeted Immunotherapy Approach Developed

share: This news release, issued by Johns Hopkins Medicine, describes a novel targeted immunotherapy approach. This new approach employs bispecific antibodies to treat cancer by eliciting a Tcell response against mutated p53. The researchers used the Highly Automated Macromolecular Crystallography (AMX) and Frontier Microfocusing Macromolecular Crystallography (FMX) beamlines to characterize the molecular structure of the proteins. AMX and FMX are beamlines at the National Synchrotron Light Source II (NSLS-II)—a U.S. Department of Energy (DOE) Office of Science User Facility at Broo...

Source: bnl.gov
Bispecific antibodies targeting mutant RAS neoantigens - Vimarsana News

Bispecific antibodies targeting mutant RAS neoantigens

Diabodies see the unseeable RAS oncogene mutations are common in various cancers, controlling their growth and survival. Targeting mutant RAS proteins with antibodies has been unsuccessful due to low surface expression, even when targeting mutant RAS peptides presented via HLA on the surface of cancer cells. Douglass et al. used phage display to generate single-chain variable fragments (scFvs) specific for mutant RAS peptide-HLA complexes. The authors tested various bispecific, T cell–engaging antibody formulations, finding that single-chain diabodies (scDbs) combining the aforementioned s...

Mutant gene-targeted immunotherapy approach developed - Vimarsana News

Mutant gene-targeted immunotherapy approach developed

Two of the three research studies -- led by Jacqueline Douglass, M.D., Ph.D. candidate at the Johns Hopkins University School of Medicine and Emily Han-Chung Hsiue, M.D., Ph.D., postdoctoral fellow at Johns Hopkins--report on a precision medicine immunotherapy approach that specifically kills cancer cells by targeting mutant protein fragments presented as antigens on the cancer cell surface. Although common across cancer types, p53 mutations have not been successfully targeted with drugs. Genetic alterations in tumor suppressor genes often resulted in their functional inactivation. "Tradition...